Reactivation of chronic hepatitis B infection related to imatinib mesylate therapy - Wikidata - awgldk - TriplyDB

Reactivation of chronic hepatitis B infection related to imatinib mesylate therapy

Reactivation of chronic hepatitis B infection related to imatinib mesylate therapy

http://www.wikidata.org/entity/Q41892625

about

Prevention of Hepatitis B reactivation in the setting of immunosuppression European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia Risk of Infectious Complications in Hemato-Oncological Patients Treated with Kinase Inhibitors Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy Hepatotoxicity of targeted therapy for cancer.Cost Effectiveness of Universal Hepatitis B Virus Screening in Patients Beginning Chemotherapy for Sarcomas or GI Stromal Tumors.Hepatitis B reactivation in the setting of chemotherapy and immunosuppression - prevention is better than cure.Hepatitis B reactivation in chronic myeloid leukemia patients receiving tyrosine kinase inhibitor.Abelson tyrosine kinase controls phagosomal acidification required for killing of Mycobacterium tuberculosis in human macrophages Prevention and management of hepatitis B virus reactivation in cancer patients.Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions.Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment.Hepatitis B reactivation in patients receiving targeted therapies.Risk of hepatitis B reactivation under treatment with tyrosine-kinase inhibitors for chronic myeloid leukemia.Imatinib-induced Hepatitis in a Patient Treated for Gastrointestinal Stromal Tumor: A Rare Adverse Effect.

P2860

Q26747023-93A2CC61-E5A4-466C-B7D7-59A60AA6C625 Q26749324-A3AB24AE-7BD7-41C6-8CE0-256FFC813E1B Q26851417-CEFB8B2F-B02B-4C4B-9449-7C505A9306DC Q28070090-41CE4A31-0AB5-46A9-941A-24511FF9F8FF Q30250288-A215C5B5-A835-4007-898B-128CF7C11C12 Q33872813-198F91ED-FCCC-4A48-8F59-2137FCB22108 Q35567748-3EC13522-7F7B-463C-AC55-C743256F7227 Q36654518-2DD472DF-93CB-4899-ACAF-AACEF9AD8575 Q36934732-5A2B5B79-DD61-4766-9974-162550E86F0B Q38688782-4FF318AC-9FEC-420A-91FB-8C4AFF5FFCF2 Q38755178-D108FFA3-2EDF-412E-B822-C701226F690A Q38996149-E35C27F4-420C-477C-80A7-69D2585B16CE Q39293427-1953C6AA-AFE9-4128-82B2-45CD48DD7EB4 Q55007608-5AFCECB8-BBD4-47B3-973F-690C5ED4E897 Q55276033-D2972D9B-22C4-450A-9F76-D465F13CA43C

P2860

Reactivation of chronic hepatitis B infection related to imatinib mesylate therapy

http://www.wikidata.org/entity/Q41892625

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Reactivation of chronic hepatitis B infection related to imatinib mesylate therapy

@en

type

label

Reactivation of chronic hepatitis B infection related to imatinib mesylate therapy

@en

prefLabel

Reactivation of chronic hepatitis B infection related to imatinib mesylate therapy

@en

P1433

Q41892625-98D75EC7-E92E-451D-AB59-6230CE380959

P1476

Q41892625-9F4F1556-FD42-43EF-8A0D-145ED3436CFF

P2093

Q41892625-82A807E1-E171-489A-B90C-D5EE1E3DC8ED

Q41892625-A7A070CF-C483-4A33-8B15-0DDEE99036AA

Q41892625-C7B7340D-A63D-42FE-AFD2-BDD8F9720902

Q41892625-F16E8AD6-C83A-4DDF-8D49-05BA17B04359

P2860

Q41892625-303FC892-18BF-40C8-A908-E62689E83D99

Q41892625-371D05B4-55DF-4BCA-B8AC-D4D7D7CF3438

Q41892625-7D5F1B15-9EE1-40BD-B481-8A08A258CDDD

Q41892625-9E0B877A-57DD-4955-A0FA-0E6039DCD542

Q41892625-CD48A7DD-8C6E-445D-8122-EAA201626E7D

P2888

Q41892625-B67C47B0-0CB0-49DB-A114-8755FF201B70

P304

Q41892625-8CEA4ED5-6DAF-40FF-B9B6-07A9425D0062

P31

Q41892625-0370af94-6962-4607-a2ce-77a89354eed1

Q41892625-1A247DB5-FE40-4B0F-86E1-9690E4A9F3E9

P356

Q41892625-C1EADFEB-F114-41C8-A6F5-CE887E93B91E

P433

Q41892625-334FFE37-17A5-4E6C-97BB-B84AA0CFD698

P478

Q41892625-46B182F0-DD0B-49D2-8E23-B2AA0F717E1D

P577

Q41892625-E8DA313E-0955-49F5-BF96-A61F0B9B93A9

P5875

Q41892625-8AFCF680-28F3-4253-ACC2-CA51A0E700FE

P698

Q41892625-EA78ABAC-ECA3-4455-96C6-029843CF9DC7

P932

Q41892625-B035C673-A239-4054-9F88-086F7160A573

P356

S12072-008-9099-5

P1433

Hepatology international

P1476

Reactivation of chronic hepatitis B infection related to imatinib mesylate therapy

@en

P2093

Averell H Sherker

http://www.w3.org/2001/XMLSchema#string

Dennis A Priebat

http://www.w3.org/2001/XMLSchema#string

Lev Davidson

http://www.w3.org/2001/XMLSchema#string

Shilen Lakhani

http://www.w3.org/2001/XMLSchema#string

P2860

Gastrointestinal stromal tumour.

Response of extraabdominal desmoid tumors to therapy with imatinib mesylate.

Histological features of acute hepatitis after imatinib mesylate treatment.

Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells.

Fatal hepatitis B virus reactivation in a chronic myeloid leukemia patient during imatinib mesylate treatment.

P2888

s12072-008-9099-5

P304

498-499

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12072-008-9099-5

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26730892

http://www.w3.org/2001/XMLSchema#string

P698

19669326

http://www.w3.org/2001/XMLSchema#string

P932

2716906

http://www.w3.org/2001/XMLSchema#string